Coherus BioSciences (CHRS) Income Statement

Click line-items for a historical chart and %

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME [Abstract]
Net sales	481.26M
Cost of goods sold	219.53M
Gross profit	261.73M
Occupancy and buying expenses	81.34M
Selling, general, and administrative expenses	137.78M
Depreciation and amortization	14.21M
Gain from sale of office premises	0
Total operating expenses	234.36M
Income/(loss) from operations	27.38M
Other income	348K
Gain on repurchases of 1.125% Senior Convertible Notes
Interest expense	-3.14M
Income/(loss) before income taxes
Income tax provision/(benefit)	6.81M
Net income/(loss)	17.77M
Basic net income per share:
Basic net income/(loss) per share	0.15
Diluted net income per share:
Diluted net income/(loss) per share	0.15

Entities mentioned with CHRS